KARAHCO AS.
Startup for implementation, monitoring and evaluation of MedTech and healthcare projects in Norway and abroad
KARAHCO AS is a Norwegian limited company (Aksjeselskap) founded in August 2021, as a reproduction of KARAHCO, a sole proprietorship (Enkeltpersonforetak) founded in 2015. The three main pipelines of services provided by KARAHCO AS are: Bacterial genome analysis, innovative molecular testing of pathogens, and external monitoring and evaluation of healthcare projects.
By generating new ideas and solutions, we aim to challenge the current status quo of clinical microbiology testing technology
We aim to make positive and measurable impacts on people, society, and the environment alongside with meeting our financial expectations
Introducing new microbiology diagnostic routines to handle global public health concerns of antibiotic resistance and emerging pathogens
If you have an enquiry about our products or services, please get in touch using our contact details below or by completing the online form